Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group
Claudia Sargas, Rosa Ayala, María José Larráyoz, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Outcomes and genetic dynamics of acute myeloid leukemia at first relapse
Àlex Bataller, Hagop M. Kantarjian, Alexandre Bazinet, et al.
Haematologica (2024)
Open Access | Times Cited: 5
Assessment of 2022 European LeukemiaNet risk classification system in real‐world cohort from China
Enbo Chen, Changqing Jiao, Jian Yu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 24, pp. 21615-21626
Open Access | Times Cited: 5
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry
Jorge Labrador, David Martínez‐Cuadrón, Blanca Boluda, et al.
Cancer (2024) Vol. 130, Iss. 20, pp. 3436-3451
Closed Access | Times Cited: 1
Characteristics, outcomes and health care utilization of patients with acute myeloid leukemia aged 70 years or older: A single‐center retrospective analysis
Marie Anne‐Catherine Neumann, Jan‐Hendrik Naendrup, Jorge Garcia Borrega, et al.
Hematological Oncology (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Dynamics of measurable residual disease for risk stratification and guiding allogeneic transplant in acute myeloid leukaemia patients with myelodysplasia‐related mutations in first remission
Ling Jiang, Jiaying Cheng, Junya Sun, et al.
British Journal of Haematology (2024)
Open Access | Times Cited: 1
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?
Edwin Uriel Suárez, Blanca Boluda, Esperanza Lavilla, et al.
Annals of Hematology (2024)
Closed Access
Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study
Christa L. Meyer, Theresa H.M. Keegan, Ann Brunson, et al.
Haematologica (2024)
Open Access
Comparison of disease and risk classifications of AML before and after incorporation of NGS analysis of bone marrow samples
Hiroyuki Sugiura, T Ishikawa, Taiga Kuroi, et al.
International Journal of Hematology (2024)
Closed Access
Acute myeloid leukemia risk stratification in younger and older patients through transcriptomic machine learning models
Raíssa Silva, Cédric Riedel, Maïlis Amico, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The Clinical Impact of NPM1 Mutations and the Effect of Concurrent Mutations in Acute Myeloid Leukemia: Unraveling the Prognostic Significance
Faten Moassass, Yahia Moualla, Bassel Al‐Halabi, et al.
Health Science Reports (2024) Vol. 7, Iss. 12
Closed Access
Reclassification of Acute Myeloid Leukemia According to the 2022 World Health Organization Classification and the International Consensus Classification Using Open-Source Data
Jiwon Yun
Annals of Laboratory Medicine (2024)
Open Access
Page 1

Scroll to top